International Assets Investment Management LLC Raises Holdings in Phreesia, Inc. (NYSE:PHR)

International Assets Investment Management LLC grew its holdings in Phreesia, Inc. (NYSE:PHR) by 2,179.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,459 shares of the company’s stock after purchasing an additional 1,395 shares during the period. International Assets Investment Management LLC’s holdings in Phreesia were worth $33,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of PHR. Capital International Investors grew its position in Phreesia by 221.1% in the 1st quarter. Capital International Investors now owns 2,593,063 shares of the company’s stock worth $62,052,000 after purchasing an additional 1,785,463 shares during the period. Champlain Investment Partners LLC bought a new stake in shares of Phreesia in the first quarter worth $29,941,000. Blair William & Co. IL increased its position in Phreesia by 42.6% during the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock valued at $18,012,000 after acquiring an additional 224,950 shares during the last quarter. Deerfield Management Company L.P. Series C bought a new position in Phreesia in the second quarter valued at about $4,078,000. Finally, Sei Investments Co. lifted its holdings in Phreesia by 135.3% in the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after acquiring an additional 95,058 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Analysts Set New Price Targets

PHR has been the subject of several research reports. JPMorgan Chase & Co. upped their price target on shares of Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Monday, September 9th. DA Davidson reaffirmed a “buy” rating and set a $32.00 target price on shares of Phreesia in a report on Thursday, September 5th. Royal Bank of Canada reiterated a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a research note on Friday, September 27th. Truist Financial boosted their price objective on shares of Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, September 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Thursday, September 5th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, Phreesia has an average rating of “Moderate Buy” and an average target price of $29.42.

Phreesia Price Performance

Shares of Phreesia stock opened at $21.25 on Friday. The company has a market capitalization of $1.23 billion, a price-to-earnings ratio of -11.81 and a beta of 0.94. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The stock’s 50-day simple moving average is $21.65 and its 200-day simple moving average is $22.03. Phreesia, Inc. has a 52 week low of $14.28 and a 52 week high of $29.16.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.06. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. The company had revenue of $102.12 million for the quarter, compared to analysts’ expectations of $101.76 million. As a group, analysts expect that Phreesia, Inc. will post -1.23 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Yvonne Hui sold 2,791 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $20.92, for a total transaction of $58,387.72. Following the completion of the transaction, the insider now owns 27,228 shares in the company, valued at $569,609.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, General Counsel Allison C. Hoffman sold 14,110 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $26.03, for a total transaction of $367,283.30. Following the sale, the general counsel now owns 121,003 shares of the company’s stock, valued at $3,149,708.09. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Yvonne Hui sold 2,791 shares of Phreesia stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $20.92, for a total transaction of $58,387.72. Following the completion of the transaction, the insider now directly owns 27,228 shares of the company’s stock, valued at $569,609.76. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 44,107 shares of company stock worth $1,035,226. 5.80% of the stock is owned by insiders.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.